Canaccord analyst Kyle Mikson raised the price target on Biodesix (NASDAQ: BDSX) to $35.00 (from $27.00) while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE